Simcere Pharmaceutical Group

About Simcere Pharmaceutical Group

Simcere Pharmaceutical Group is a leading biopharmaceutical company based in the UK, dedicated to the research, development, and commercialization of innovative medicines. Established with a vision to improve patient outcomes, Simcere focuses on therapeutic areas such as oncology, central nervous system disorders, and autoimmune diseases.

The company prides itself on its robust pipeline of products, which includes both proprietary and partnered therapies. With a commitment to scientific excellence, Simcere invests heavily in research and development, collaborating with academic institutions and industry partners to advance its drug discovery efforts.

Simcere’s mission is to deliver high-quality, affordable medications that meet the needs of patients worldwide. The company adheres to stringent regulatory standards and maintains a strong emphasis on quality assurance throughout its manufacturing processes.

In addition to its core pharmaceutical activities, Simcere is also involved in various corporate social responsibility initiatives aimed at enhancing healthcare access and education in underserved communities.

• Core Activities: Research and Development, Manufacturing, Marketing, and Distribution of Pharmaceuticals.
• Vision: To be a global leader in biopharmaceutical innovation.
• Commitment: Quality, Affordability, and Patient-Centric Solutions.

With a dedicated team of professionals and a passion for improving health outcomes, Simcere Pharmaceutical Group continues to make significant strides in the biopharmaceutical landscape.